Production of adenovirus vectors and their use as a delivery system for influenza vaccines.
BACKGROUND
With the emergence of highly pathogenic avian influenza H5N1 viruses that have crossed species barriers and are responsible for lethal infections in humans in many countries, there is an urgent need for the development of effective vaccines which can be produced in large quantities at a short notice and confer broad protection against these H5N1 variants. In order to meet the potential global vaccine demand in a pandemic scenario, new vaccine-production strategies must be explored in addition to the currently used egg-based technology for seasonal influenza.


METHODS
Adenovirus (Ad) based influenza vaccines represent an attractive alternative/supplement to the currently licensed egg-based influenza vaccines. Ad-based vaccines are relatively inexpensive to manufacture, and their production process does not require either chicken eggs or labor-intensive and time-consuming processes necessitating enhanced biosafety facilities. Most importantly, in a pandemic situation, this vaccine strategy could offer a stockpiling option to reduce the response time before a strain-matched vaccine could be developed.


RESULTS
This review discusses Ad-vector technology and the current progress in the development of Ad-based influenza vaccines.


CONCLUSIONS
Ad vector-based influenza vaccines for pandemic preparedness are under development to meet global vaccine demand.
Vemula
Sai V
SV
Purdue University, Bindley Bioscience Center, School of Veterinary Medicine, Department of Comparative Pathobiology, West Lafayette, IN 47907, USA.
Mittal
Suresh K
SK
D000256:Adenoviridae / Q000235:genetics* / Q000276:immunology; D000818:Animals; D002959:Civil Defense; D005822:Genetic Vectors / Q000096:biosynthesis* / Q000276:immunology; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000235:genetics / Q000276:immunology*; D007252:Influenza Vaccines / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology / Q000600:supply & distribution; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D058873:Pandemics / Q000517:prevention & control*; D019444:Vaccines, DNA / Q000096:biosynthesis
D007252:Influenza Vaccines; D019444:Vaccines, DNA
J Infect Dis. 2006 Dec 15;194(12):1638-49
17109335
Gene Ther. 2003 Nov;10(23):1941-9
14528318
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6763-7
2570422
Gene Ther. 2002 Dec;9(24):1722-9
12457287
Vaccine. 2006 Apr 24;24(17):3440-5
16527377
Gene Ther. 2010 May;17(5):634-42
20164856
Am J Vet Res. 2005 Nov;66(11):1943-7
16334954
J Virol. 2000 Jan;74(1):505-12
10590140
Virology. 1998 Oct 10;250(1):220-9
9770436
Am J Public Health. 2009 Oct;99 Suppl 2:S225-30
19797736
Hum Gene Ther. 1999 Apr 10;10(6):965-76
10223730
Lancet. 1999 Sep 11;354(9182):916-7
10489954
Pharm Dev Technol. 1998 Aug;3(3):365-72
9742557
Vaccine. 2005 Jan 11;23(8):1029-36
15620476
Nature. 2002 Jan 17;415(6869):331-5
11797011
Vet Microbiol. 2006 Nov 26;118(1-2):67-75
16939702
J Immunol. 2004 May 15;172(10):6290-7
15128818
Hum Gene Ther. 2005 Mar;16(3):281-91
15812223
Virology. 2003 Jul 5;311(2):384-93
12842627
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4407-11
8183921
J Virol. 2004 Jun;78(11):5966-72
15140994
J Virol. 1996 Dec;70(12):8944-60
8971024
Biotechnology (N Y). 1993 Feb;11(2):173-8
7763369
Hematol Oncol Clin North Am. 2006 Jun;20(3):661-87
16762729
Hum Gene Ther. 2002 Nov 1;13(16):1921-34
12427304
J Virol. 2003 Nov;77(22):11941-51
14581531
Gene Ther. 1996 Feb;3(2):137-44
8867861
Vaccine. 2008 May 19;26(21):2627-39
18395306
Hum Gene Ther. 2002 Feb 10;13(3):367-79
11860704
Clin Infect Dis. 2008 Jun 1;46(11):1769-81
18433307
J Immunol. 1993 Nov 15;151(10):5145-53
7693805
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7777-81
1502197
J Gen Virol. 1994 Jan;75 ( Pt 1):125-31
8113721
Cell. 2009 Jun 12;137(6):983-5
19524497
J Clin Invest. 2005 May;115(5):1281-9
15841217
Annu Rev Med. 2004;55:355-72
14746526
Vaccine. 2004 Sep 3;22(25-26):3427-34
15308368
Vaccine. 2005 Nov 16;23(46-47):5404-10
16011865
Mil Med. 1995 Jun;160(6):300-4
7659229
Int Rev Immunol. 2008;27(6):392-426
19065349
Nat Med. 2003 Nov;9(11):1408-12
14566335
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6186-90
8016135
AIDS Res Hum Retroviruses. 1994 Nov;10(11):1443-9
7888199
J Gen Virol. 1987 Feb;68 ( Pt 2):433-40
3493324
Nat Rev Genet. 2003 May;4(5):346-58
12728277
J Virol. 2003 Sep;77(18):10078-87
12941918
J Virol. 1998 Feb;72(2):1394-402
9445040
Biotechnol Prog. 1999 Jul-Aug;15(4):608-16
10441351
J Virol. 1997 Mar;71(3):1842-9
9032314
J Virol. 2005 Nov;79(22):14161-8
16254351
Vaccine. 1991 Jul;9(7):485-90
1832806
J Virol Methods. 1999 Feb;77(2):125-9
10092136
J Virol. 2002 Feb;76(4):1559-68
11799150
Immunity. 1994 Aug;1(5):433-42
7533647
J Gen Virol. 1985 Jun;66 ( Pt 6):1327-31
3874261
Infect Immun. 2006 Aug;74(8):4634-43
16861651
Clin Pharmacol Ther. 2007 Dec;82(6):665-71
17957181
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13565-70
8942974
Gene Ther. 2003 Jun;10(11):955-63
12756416
Biotechnol Bioeng. 2002 Dec 5;80(5):569-79
12355468
J Gen Virol. 1999 Mar;80 ( Pt 3):563-570
10091994
Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L393-401
15107295
J Virol. 2001 Dec;75(23):11603-13
11689642
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13282-7
11687662
Hum Gene Ther. 1997 Mar 1;8(4):453-65
9054520
Curr Gene Ther. 2006 Apr;6(2):215-26
16611043
Hum Gene Ther. 2001 Jul 20;12(11):1383-94
11485630
J Immunol. 1995 Sep 1;155(5):2564-70
7650386
Expert Opin Drug Deliv. 2008 Oct;5(10):1139-57
18817518
J Virol. 2004 Dec;78(23):13207-15
15542673
Vaccine. 2000 Sep 15;19(2-3):253-63
10930680
Ned Tijdschr Geneeskd. 1999 Oct 2;143(40):1988-91
10535054
Curr Gene Ther. 2002 May;2(2):161-71
12109213
J Infect Dis. 2005 Sep 1;192(5):920-9
16088843
Hum Gene Ther. 1995 Nov;6(11):1403-16
8573613
Arch Virol. 2002 Nov;147(11):2125-41
12417948
Vaccine. 2007 May 16;25(20):4085-92
17391815
Poult Sci. 2009 Apr;88(4):867-71
19276437
J Virol. 2006 Feb;80(4):1959-64
16439551
Expert Rev Vaccines. 2008 Feb;7(1):25-31
18251691
Mol Med. 1999 Apr;5(4):224-31
10448644
Nat Protoc. 2007;2(5):1236-47
17546019
Mol Ther. 2007 Jan;15(1):203-10
17164792
Mol Ther. 2008 May;16(5):965-71
18301400
Vaccine. 2008 Apr 16;26(17):2062-72
18378366
Hum Gene Ther. 1996 Aug 20;7(13):1555-66
8864756
Cytotechnology. 2001 Nov;37(3):189-98
19002922
J Virol. 2000 May;74(9):3941-7
10756005
Virology. 1995 Jun 20;210(1):226-30
7793076
Science. 2010 Aug 27;329(5995):1060-4
20647428
Circulation. 2001 Mar 6;103(9):1274-81
11238273
Virology. 2009 Mar 30;386(1):44-54
19211122
Science. 1998 Jan 16;279(5349):393-6
9430591
Front Biosci. 2005 May 01;10:1098-105
15769609
Science. 1993 Mar 19;259(5102):1745-9
8456302
Mol Ther. 2001 May;3(5 Pt 1):708-22
11356076
Nature. 2003 Aug 7;424(6949):681-4
12904795
Mol Ther. 2010 Oct;18(10):1874-84
20664527
Lancet. 2006 Feb 11;367(9509):475-81
16473124
J Virol. 2005 Apr;79(8):5090-104
15795294
Gene Ther. 2005 Oct;12 Suppl 1:S103-10
16231042
Cytotechnology. 1999 Jul;30(1-3):169-72
19003366
J Virol. 2002 May;76(9):4181-9
11932383
PLoS One. 2010 May 05;5(5):e10492
20463955
PLoS One. 2008;3(10):e3548
18958172
Virology. 1995 Jul 10;210(2):456-65
7618280
J Virol. 1995 Apr;69(4):2004-15
7884845
J Virol. 1985 Jun;54(3):711-9
3999192
Curr Gene Ther. 2007 Aug;7(4):229-38
17969556
J Immunol. 2008 Aug 1;181(3):2134-44
18641352
Curr Opin Mol Ther. 2000 Aug;2(4):376-82
11249767
Hum Gene Ther. 2004 Dec;15(12):1157-66
15684693
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12816-21
10536005
Biotechnol Prog. 1997 Nov-Dec;13(6):709-14
9413130
Nature. 1997 Oct 9;389(6651):554
9335492
Adv Biochem Eng Biotechnol. 2005;99:193-260
16568893
J Infect Dis. 1992 Oct;166(4):769-75
1527411
Hum Gene Ther. 1998 Dec 10;9(18):2709-16
9874269
Cytotechnology. 1994;15(1-3):145-55
7765926
J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8
17163383
Biotechnol Bioeng. 1998 Sep 5;59(5):567-75
10099373
J Virol. 2000 Sep;74(17):7787-93
10933685
Clin Vaccine Immunol. 2009 Sep;16(9):1285-92
19605598
J Exp Med. 2008 Jan 21;205(1):7-12
18195078
J Gen Virol. 2000 Jul;81(Pt 7):1833-7
10859390
J Virol. 2007 Apr;81(7):3170-80
17229689
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2509-14
9482916
Blood. 2004 Feb 1;103(3):804-10
14512318
Hum Gene Ther. 2001 Jul 20;12(11):1369-82
11485629
J Virol. 2000 Oct;74(20):9617-28
11000234
Biotechnol Prog. 2008 Nov-Dec;24(6):1290-6
19194943
Emerg Infect Dis. 2002 Aug;8(8):796-801
12141964
Viral Immunol. 2005;18(2):283-91
16035940
J Immunol. 2005 Jun 1;174(11):7179-85
15905562
AIDS Res Hum Retroviruses. 1993 May;9(5):395-404
8318268
Clin Diagn Lab Immunol. 2004 Mar;11(2):351-7
15013987
Virus Res. 2004 Oct;105(2):127-36
15351486
PLoS One. 2010 Mar 23;5(3):e9812
20352112
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8802-6
8090727
J Infect Dis. 2008 Apr 15;197(8):1185-8
18462165
J Virol. 1998 Dec;72(12):10260-4
9811772
Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785-9
3872457
Biotechnol Bioeng. 2003 Jul 5;83(1):45-52
12740932
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7866-71
9653106
Mol Ther. 2008 Feb;16(2):237-43
18071338
Hum Gene Ther. 1999 Nov 1;10(16):2667-72
10566894
Gene Ther. 2003 Jun;10(11):935-40
12756413
J Infect Dis. 2010 May 1;201(9):1390-6
20331380
Hum Gene Ther. 1999 May 20;10(8):1349-58
10365665
J Clin Microbiol. 2006 Oct;44(10):3781-3
17021110
Infect Immun. 2005 Oct;73(10):6885-91
16177368
Virology. 2000 Jun 20;272(1):159-67
10873758
Avian Pathol. 2004 Apr;33(2):164-70
15276983
Vaccine. 2008 May 19;26(21):2640-6
18384919
J Virol. 1981 Jan;37(1):171-80
6260971
Vaccine. 2006 Feb 13;24(7):849-62
16297508
Vaccine. 2007 Sep 28;25(39-40):6845-51
17728024
Hum Gene Ther. 2000 Mar 20;11(5):693-9
10757349
Science. 2005 Oct 7;310(5745):77-80
16210530
J Virol. 2007 Apr;81(8):4145-57
17251283
JAMA. 2003 Jan 8;289(2):179-86
12517228
J Gen Virol. 1995 Jan;76 ( Pt 1):93-102
7844546
J Virol. 1996 Jul;70(7):4805-10
8676512
J Virol. 2006 Jun;80(11):5523-30
16699033
Hum Gene Ther. 2007 Aug;18(8):753-62
17685831
Emerg Infect Dis. 2007 Mar;13(3):426-35
17552096
J Virol. 2005 Aug;79(15):9694-701
16014931